Quick Answer
Kalaris Therapeutics, Inc. reported Common Stock Shares Outstanding of 22.90 million shares for the year ending 2025.
- Kalaris Therapeutics, Inc. showed an increase of +1,588.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Kalaris Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Kalaris Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 990.7%.
- Historical annual values: Fiscal year 2025: 22.90 million shares | Fiscal year 2024: 1.36 million shares | Fiscal year 2023: 4.96 million shares | Fiscal year 2022: 93.09 million shares | Fiscal year 2021: 63.57 million shares | Fiscal year 2020: 61.93 million shares | Fiscal year 2019: 2.10 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: